Harrow Health, Inc.
NASDAQ:HROW
49.91 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 130.193 | 88.595 | 72.476 | 48.871 | 51.165 | 41.372 | 26.774 | 19.942 | 9.716 | 1.66 | 0.01 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 39.64 | 25.383 | 18.214 | 14.463 | 16.749 | 16.521 | 13.505 | 9.831 | 5.206 | 1.093 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 90.553 | 63.212 | 54.262 | 34.408 | 34.416 | 24.851 | 13.269 | 10.111 | 4.51 | 0.567 | 0.01 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.696 | 0.713 | 0.749 | 0.704 | 0.673 | 0.601 | 0.496 | 0.507 | 0.464 | 0.342 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 6.883 | 3.05 | 11.084 | 2.413 | 2.083 | 0.825 | 0.413 | 0.739 | 0.332 | 0.237 | 1.616 | 1.299 | 0.112 | 0.195 | 2.966 | 1.991 | 1.833 | 0.15 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 17.96 | 17.569 | 12.504 | 8.087 | 5.892 | 0 | 0 | 0 | 0 | 0 | 0 | 0.43 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 7.059 | 7.382 | 6.496 | 2.39 | 0.086 | 0 | 0 | 0 | 0 | 0 | 0 | -0.424 |
| SG&A
| 83.09 | 58.243 | 41.315 | 31.247 | 33.096 | 29.243 | 25.019 | 24.951 | 19 | 10.477 | 6.081 | 2.98 | 0.828 | 2.308 | 1.598 | 1.756 | 2.859 | 0.006 |
| Other Expenses
| -0.444 | -15.93 | -19.488 | -3.8 | 0.63 | 0.103 | 0 | 1.537 | 0.031 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.11 |
| Operating Expenses
| 89.973 | 61.293 | 52.399 | 33.66 | 35.179 | 30.068 | 25.432 | 25.69 | 19.332 | 10.714 | 7.697 | 4.279 | 0.939 | 2.503 | 4.564 | 3.746 | 2.859 | 0.046 |
| Operating Income
| 0.58 | -1.746 | -0.284 | -1.632 | -0.503 | -5.217 | -12.163 | -15.882 | -14.822 | -10.147 | -7.687 | -4.179 | -0.939 | -2.503 | -4.564 | -3.746 | -2.859 | -0.046 |
| Operating Income Ratio
| 0.004 | -0.02 | -0.004 | -0.033 | -0.01 | -0.126 | -0.454 | -0.796 | -1.526 | -6.112 | -768.688 | -41.789 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -24.521 | -12.265 | -17.59 | -1.783 | 0.378 | 22.57 | 2.269 | -0.845 | 0.031 | 0.029 | 0.044 | -1.195 | 0.06 | 0.026 | 0 | 0.375 | 0.09 | -0.534 |
| Income Before Tax
| -23.941 | -14.011 | -17.874 | -3.415 | -0.125 | 14.625 | -12.92 | -19.198 | -15.899 | -10.118 | -7.643 | -5.384 | -0.954 | -2.531 | 0 | -3.371 | -2.769 | -0.58 |
| Income Before Tax Ratio
| -0.184 | -0.158 | -0.247 | -0.07 | -0.002 | 0.353 | -0.483 | -0.963 | -1.636 | -6.094 | -764.312 | -53.835 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.47 | 0.075 | 0.133 | 0.004 | 2.467 | -19.449 | -0.935 | -0.111 | 1.077 | -0.029 | -0.044 | 1.195 | -0.06 | -0.026 | -0.01 | -0.817 | -0.228 | 0.01 |
| Net Income
| -24.411 | -14.086 | -18.007 | -3.419 | -2.592 | 14.625 | -11.985 | -19.087 | -15.899 | -10.118 | -7.643 | -5.384 | -0.954 | -2.531 | -4.554 | -3.304 | -4.285 | -0.046 |
| Net Income Ratio
| -0.187 | -0.159 | -0.248 | -0.07 | -0.051 | 0.353 | -0.448 | -0.957 | -1.636 | -6.094 | -764.312 | -53.835 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.75 | -0.51 | -0.67 | -0.13 | -0.1 | 0.61 | -0.6 | -1.5 | -1.66 | -1.11 | -0.88 | -1.2 | -2.4 | -6.41 | -11.67 | -8.92 | -19.37 | -0.25 |
| EPS Diluted
| -0.75 | -0.51 | -0.67 | -0.13 | -0.098 | 0.61 | -0.6 | -1.5 | -1.66 | -1.11 | -0.88 | -1.2 | -2.4 | -6.41 | -11.67 | -8.92 | -19.37 | -0.25 |
| EBITDA
| 12.92 | 1.919 | 2.112 | 1.111 | 2.16 | -2.981 | -14.885 | -11.791 | -14.212 | -10.029 | -7.637 | -4.161 | -0.939 | -2.501 | -4.563 | -4.121 | -2.748 | -0.046 |
| EBITDA Ratio
| 0.099 | 0.022 | 0.029 | 0.023 | 0.042 | -0.072 | -0.556 | -0.591 | -1.463 | -6.041 | -763.747 | -41.605 | 0 | 0 | 0 | 0 | 0 | 0 |